In 2012, PrEPFacts.org became the first informational PrEP resource online. The creation of the site and accompanying informational materials was a collaboration of San Francisco AIDS Foundation, San Francisco Department of Public Health, Project Inform, Be The Generation, Gilead Sciences and other local health agencies, community-based providers, and PrEP advocates.
PrEP, which stands for pre-exposure prophylaxis, is an effective way to prevent HIV that involves taking medication either daily or around the times you have sex. If you’re new to PrEP or want to learn more about who it’s for, how to access it, the research supporting it and how effective it is, check out PrEPFacts.org to learn more.
PrEPfacts.org answers your questions about research, best practices for staying healthy, where to get a prescription and more. Visit PrEPfacts.org to learn more.
We’ve also made PrEPfacts.org campaign materials available for download in the virtual asset library. Providers all over the country have used these materials in their own clinics to share education about the effectiveness of PrEP.
What we know about Descovy’s impact on weight & cholesterol
HIV advocates have raised concerns about the metabolic effects that Descovy (F/TAF) may have on people living with HIV and people taking it for PrEP. Here’s what we know.
Advancing policies to solve PrEP access issues
Our policy & PrEP team helped advance groundbreaking legislation allowing PrEP and PEP to be offered in pharmacies without a prescription.
FDA approves Descovy (F/TAF) for PrEP
We now have a new medication for PrEP. Here's how Descovy (F/TAF) is different than Truvada (F/TDF).
Truvada Lawsuit Ads are Misleading
Truvada is a well-studied medication that is safe for the vast majority of people taking it for PrEP and for HIV treatment.
34% of transmasculine people given PrEP info by providers
Transmasculine individuals need access to sexual health care and PrEP information, without assumptions or judgment about sexual preferences.
IAS 2019 – PrEP use by transmasculine & transfeminine folks: New data from Northern California
In a sample of more than 2,500 transgender clients receiving care from a large managed health care system, only 16% with an indication for PrEP were linked to PrEP care.
IAS 2019 – Personal agency is central to ending the HIV epidemic
PrEP advocate Damon L. Jacobs explains why agency -- the personal freedom of choice and equal access -- is critical and how access to information and research is an essential component.
No effect of cocaine and PrEP on kidneys, but adherence suffers
Using hair samples to quantify cocaine use history, researchers found that both “light” and “heavy” use was associated with less consistent PrEP dosing.